Illustrative image – not actual. J B Chemicals & Pharmaceuticals (JBCPL) has signed an agreement to sell its prescription medicine portfolio to Dr Reddy's Laboratories.
The agreement involves acquisition of 20 brands, key ones being Metrogyl and Jocet, for a consideration of Rs 137.5 crore. DRL has also entered into a supply agreement with J B Chemicals for the continued manufacturing and supply of these products associated with the acquired brands. Bank of America Merrill Lynch is acting as exclusive financial advisor to JBCPL.
The agreement involves acquisition of 20 brands, key ones being Metrogyl and Jocet, for a consideration of Rs 137.5 crore. DRL has also entered into a supply agreement with J B Chemicals for the continued manufacturing and supply of these products associated with the acquired brands. Bank of America Merrill Lynch is acting as exclusive financial advisor to JBCPL.
